Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Portage Biotech Inc. (PRTG : NSDQ)

• Company Description    Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $8.14 Daily Weekly Monthly 20 Day Moving Average: 40,892 shares Shares Outstanding: 13.35 (millions) Market Capitalization: $108.63 (millions) Beta: 0.46 52 Week High: $44.98 52 Week Low: $4.62 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 38.32% 55.77% 12 Week -1.33% 8.46% Year To Date -24.14% -24.62%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Craigmuir Chambers Road Town - Tortola,D8 VG1110 - ph: 416-929-1806 fax: - None http://www.portagebiotech.com

• General Corporate Information    Officers Ian Walters - Chief Executive Officer Gregory Bailey - Chairman Allan Shaw - Chief Financial Officer Kam Shah - Director Steven Mintz - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G7185A128 SIC: 1311 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/21 Next Expected EPS Date: 07/27/22 Share - Related Items Shares Outstanding: 13.35 Most Recent Split Date: (:1) Beta: 0.46 Market Capitalization: $108.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.51 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/27/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.63 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -18.18% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - -13.23 09/30/21 - -16.07 ROA 03/31/22 - - 12/31/21 - -11.46 09/30/21 - -13.86 Current Ratio 03/31/22 - - 12/31/21 - 41.31 09/30/21 - 21.31 Quick Ratio 03/31/22 - - 12/31/21 - 41.31 09/30/21 - 21.31 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - 12.87 09/30/21 - 13.02 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©